Hint mode is switched on Switch off
For swift navigation between sections

AB Science
LEI 969500U43TVR8CCVBJ97

PDF download

Choose all Reset all
Download Cancel
Organization name
AB Science S.A.
Country name
France
Country of registration
France
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
-
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Get access Watch full tour

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

AB Science is a pharmaceutical company specializing in the research, development, and commercialization of tyrosine kinase inhibitors, a new class of targeted therapeutic molecules which act by modifying signalling pathways within cells. The company focuses its research on pathologies with high unmet medical need (cancers, inflammatory diseases and central nervous system diseases) in human and veterinary medicine.

Awards

Documentation

Stocks

Public debt by currencies

Show more Hide

Codes

  • LEI
    969500U43TVR8CCVBJ97
  • SIC
    2835 IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
  • NACE
    *** ***
  • NAICS
    *** ***
  • CIK
    0001703850
  • SIREN
    438479941
Registration is required to get access.